Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.

De Beaumont L, Pelleieux S, Lamarre-Théroux L, Dea D, Poirier J, Alzheimer’s Disease Cooperative Study
J Alzheimers Dis. 2016 Oct 04; 54(3):913-922. PMID: 27567841. Abstract